Last reviewed · How we verify

NCT04977687

Machine Learning Predict Renal Replacement Therapy After Cardiac Surgery

Completed Last updated 2 August 2021
What this trial tests

trial in Machine Learning in 2,108 participants. Completed in 1 January 2021.

Timeline
1 September 2020
Primary endpoint
1 January 2021
1 January 2021

Quick facts

Lead sponsorChinese PLA General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment2,108
Start date1 September 2020
Primary completion1 January 2021
Estimated completion1 January 2021
Sites1 location across China

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

18 and older, any sex, with Machine Learning or Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major complication which may result in adverse impact on short- and long-term mortality. The researcher here developed several prediction models based on machine learning technique to allow early identification of patients who at the high risk of unfavorable kidney outcomes. The retrospective study comprised 2108 consecutive patients who underwent cardiac surgery from January 2017 to December 2020.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Machine Learning

Currently open trials in the same condition.

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04977687.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing